Instituto Universitario de Investigación en Neuroquímica
Centro/Instituto
Hospital Regional Universitario de Málaga
Málaga, EspañaPublicaciones en colaboración con investigadores/as de Hospital Regional Universitario de Málaga (11)
2022
-
Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "diabesity"
Journal of Medicinal Chemistry, Vol. 65, Núm. 7, pp. 5449-5461
2021
-
(+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB1R antagonist/CB2R agonist that prevents diabetic nephropathy in mice
Pharmacological Research, Vol. 169
-
Cerebellar and cortical TLR4 activation and behavioral impairments in Wernicke-Korsakoff Syndrome: Pharmacological effects of oleoylethanolamide
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 108
2020
-
Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 102
2019
-
Oleoylethanolamide, neuroinflammation, and alcohol abuse
Frontiers in Molecular Neuroscience, Vol. 11
-
Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients
Scientific Reports, Vol. 9, Núm. 1
2017
-
A Positive Allosteric Modulator of the Serotonin 5-HT2C Receptor for Obesity
Journal of Medicinal Chemistry, Vol. 60, Núm. 23, pp. 9575-9584
-
Glutaminase and MMP-9 downregulation in cortex and hippocampus of LPA1 receptor null mice correlate with altered dendritic spine plasticity
Frontiers in Molecular Neuroscience, Vol. 10
2015
-
Systemic administration of oleoylethanolamide protects from neuroinflammation and anhedonia induced by LPS in rats
International Journal of Neuropsychopharmacology, Vol. 18, Núm. 6, pp. 1-14
2014
-
Tocilizumab en pacientes con artritis reumatoide activa y respuesta inadecuada a fármacos antirreumáticos modificadores de la enfermedad o antagonistas del factor de necrosis tumoral: Subanálisis de los datos españoles de un estudio abierto cercano a la práctica clínica habitual
Reumatologia Clinica, Vol. 10, Núm. 2, pp. 94-100
2013
-
Novel antiobesity agents: Synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21
Bioorganic and Medicinal Chemistry, Vol. 21, Núm. 7, pp. 1708-1716